Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine phosphate for treatment of COVID-19 pneumonia
ChiCTR2000031204Phase 2Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of chloroquine in coronavirus disease 2019 (COVID-19) and pneumonia (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Clearance time of virus RNA. Started Jan 2020; status: recruiting.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on ChiCTR2000031204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031204.